406 related articles for article (PubMed ID: 32514152)
21. Desulfation of cell surface HSPG is an effective strategy for the treatment of gallbladder carcinoma.
Yi B; Qiu Y; Ji W; Wei M; Liu C; Peng Z; Zhang Y; Quan Z; Tang Z; Su C
Cancer Lett; 2016 Oct; 381(2):349-58. PubMed ID: 27502167
[TBL] [Abstract][Full Text] [Related]
22. The deoxycholic acid targets miRNA-dependent CAC1 gene expression in multidrug resistance of human colorectal cancer.
Kong Y; Bai PS; Sun H; Nan KJ; Chen NZ; Qi XG
Int J Biochem Cell Biol; 2012 Dec; 44(12):2321-32. PubMed ID: 22903020
[TBL] [Abstract][Full Text] [Related]
23. Downregulation of BRD4 inhibits gallbladder cancer proliferation and metastasis and induces apoptosis via PI3K/AKT pathway.
Hao J; Yang Z; Wang L; Zhang Y; Shu Y; Jiang L; Hu Y; Lv W; Dong P; Liu Y
Int J Oncol; 2017 Sep; 51(3):823-831. PubMed ID: 28766687
[TBL] [Abstract][Full Text] [Related]
24. miR-324-5p inhibits gallbladder carcinoma cell metastatic behaviours by downregulation of transforming growth factor beta 2 expression.
Zhang X; Zhang L; Chen M; Liu D
Artif Cells Nanomed Biotechnol; 2020 Dec; 48(1):315-324. PubMed ID: 31858815
[TBL] [Abstract][Full Text] [Related]
25. miR-4461 inhibits the progression of Gallbladder carcinoma via regulating EGFR/AKT signaling.
Yan X; Yang P; Liu H; Zhao Y; Wu Z; Zhang B
Cell Cycle; 2022 Jun; 21(11):1166-1177. PubMed ID: 35196196
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA MINCR promotes gallbladder cancer progression through stimulating EZH2 expression.
Wang SH; Yang Y; Wu XC; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
Cancer Lett; 2016 Sep; 380(1):122-33. PubMed ID: 27345740
[TBL] [Abstract][Full Text] [Related]
27. Downregulation of stathmin 1 in human gallbladder carcinoma inhibits tumor growth in vitro and in vivo.
Wang J; Yao Y; Ming Y; Shen S; Wu N; Liu J; Liu H; Suo T; Pan H; Zhang D; Ding K; Liu H
Sci Rep; 2016 Jun; 6():28833. PubMed ID: 27349455
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA aberrations: An emerging field for gallbladder cancer management.
Chandra V; Kim JJ; Mittal B; Rai R
World J Gastroenterol; 2016 Feb; 22(5):1787-99. PubMed ID: 26855538
[TBL] [Abstract][Full Text] [Related]
29. miR-34 is associated with poor prognosis of patients with gallbladder cancer through regulating telomere length in tumor stem cells.
Jin K; Xiang Y; Tang J; Wu G; Li J; Xiao H; Li C; Chen Y; Zhao J
Tumour Biol; 2014 Feb; 35(2):1503-10. PubMed ID: 24078448
[TBL] [Abstract][Full Text] [Related]
30. METTL3-mediated N6-methyladenosine modification of DUSP5 mRNA promotes gallbladder-cancer progression.
Chen HD; Li F; Chen S; Zhong ZH; Gao PF; Gao WZ
Cancer Gene Ther; 2022 Jul; 29(7):1012-1020. PubMed ID: 34799724
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNA DILC promotes the progression of gallbladder carcinoma.
Liang C; Yang P; Han T; Wang RY; Xing XL; Si AF; Ma QY; Chen Z; Li HY; Zhang B
Gene; 2019 Apr; 694():102-110. PubMed ID: 30716440
[TBL] [Abstract][Full Text] [Related]
32. SP/NK-1R promotes gallbladder cancer cell proliferation and migration.
Deng XT; Tang SM; Wu PY; Li QP; Ge XX; Xu BM; Wang HS; Miao L
J Cell Mol Med; 2019 Dec; 23(12):7961-7973. PubMed ID: 30903649
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
[TBL] [Abstract][Full Text] [Related]
34. SPOCK1 as a potential cancer prognostic marker promotes the proliferation and metastasis of gallbladder cancer cells by activating the PI3K/AKT pathway.
Shu YJ; Weng H; Ye YY; Hu YP; Bao RF; Cao Y; Wang XA; Zhang F; Xiang SS; Li HF; Wu XS; Li ML; Jiang L; Lu W; Han BS; Jie ZG; Liu YB
Mol Cancer; 2015 Jan; 14(1):12. PubMed ID: 25623055
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA H19 contributes to gallbladder cancer cell proliferation by modulated miR-194-5p targeting AKT2.
Wang SH; Wu XC; Zhang MD; Weng MZ; Zhou D; Quan ZW
Tumour Biol; 2016 Jul; 37(7):9721-30. PubMed ID: 26803515
[TBL] [Abstract][Full Text] [Related]
36. miR-365 inhibits the progression of gallbladder carcinoma and predicts the prognosis of Gallbladder carcinoma patients.
Jiang ZB; Ma BQ; Feng Z; Liu SG; Gao P; Yan HT
Cell Cycle; 2021 Feb; 20(3):308-319. PubMed ID: 33459111
[TBL] [Abstract][Full Text] [Related]
37. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG6 regulating Hedgehog signaling pathway and affecting the biological function of gallbladder carcinoma cells through targeting miR-26b-5p.
Liu XF; Wang K; Du HC
Eur Rev Med Pharmacol Sci; 2020 Jul; 24(14):7598-7611. PubMed ID: 32744686
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer.
Jin L; Cai Q; Wang S; Wang S; Mondal T; Wang J; Quan Z
Cell Death Dis; 2018 Oct; 9(10):1017. PubMed ID: 30282996
[TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA PVT1 promoted gallbladder cancer proliferation by epigenetically suppressing miR-18b-5p via DNA methylation.
Jin L; Cai Q; Wang S; Wang S; Wang J; Quan Z
Cell Death Dis; 2020 Oct; 11(10):871. PubMed ID: 33067424
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
